Mark O Asperilla pa is categorized under Infectious Disease Specialists in Port Charlotte, FL and active since 1997.
Mark O Asperilla pa was established in 1997, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Mark Asperella at the company’s single location by writing to 3300 Tamiami Trail # 102a, Port Charlotte, Florida FL 33952 or by phoning (941) 624-4499. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Mark O Asperilla pa |
Contact Person: | Mark Asperella |
Address: | 3300 Tamiami Trail # 102a, Port Charlotte, Florida 33952 |
Phone Number: | (941) 624-4499 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1997 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Infectious Disease Specialists |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Mark O Asperilla pa was started in 1997 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Mark Asperella for inquiries that concern Mark O Asperilla pa by calling the company number (941) 624-4499, as your correspondence is most welcome. Additionally, the physical location of the single location of Mark O Asperilla pa can be found at the coordinates 26.98315,-82.09906 as well as the street address 3300 Tamiami Trail # 102a in Port Charlotte, Florida 33952.
For its online presence, you may visit Mark O Asperilla pa’s website at and engage with its social media outlets through on Twitter and on Facebook.